Monoclonal Antibody to Histamine (HA)
| Code | Size | Price |
|---|
| MAA927Ge21-20ul | 20ul | £97.00 |
Quantity:
| MAA927Ge21-100ul | 100ul | £187.00 |
Quantity:
| MAA927Ge21-200ul | 200ul | £254.00 |
Quantity:
| MAA927Ge21-1ml | 1ml | £590.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Isotype: IgG2b Kappa
Antibody Clonality: Monoclonal
Antibody Clone: 8-C2
Regulatory Status: RUO
Target Species: Species Independent
Applications:
- Chemiluminescent Immunoassay (CLIA)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunoprecipitation (IP)
Documents
Further Information
Alternative Names:
Histamin
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.01% Proclin-300, 50% glycerol.
Item Name:
Histamine
Potency (Clone Number):
8-C2
Reactivity:
Hu;
Source:
Monoclonal antibody preparation
Usage:
Immunohistochemistry: 5-20ug/mL<br/>Immunocytochemistry: 5-20ug/mL<br/>Optimal working dilutions must be determined by end user.
References
- https://pubmed.ncbi.nlm.nih.gov/32892931/" - Multiplexed fluorescence immunoassay combined with magnetic separation using upconversion nanoparticles as multicolor labels for the simultaneous detection of??
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BSA Conjugated Histamine (HIS) | CPA927Ge11 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||